Zimmer Biomet updates segment reporting and disclosures
TipRanks (Wed, 5-Aug 4:45 PM ET)
TipRanks (Wed, 5-Aug 3:10 PM ET)
Zimmer Biomet Holdings (ZBH) Gets a Buy from TD Cowen
TipRanks (Wed, 5-Aug 2:25 PM ET)
Zimmer Biomet Non-GAAP EPS of $2.07 beats by $0.06, revenue of $2.18B beats by $40M
Seeking Alpha News (Wed, 5-Aug 6:36 AM ET)
Zimmer Biomet Announces Second Quarter 2026 Financial Results
PRNewswire (Wed, 5-Aug 6:30 AM ET)
Zimmer Biomet Q2 2026 Earnings Preview
Seeking Alpha News (Tue, 4-Aug 11:50 AM ET)
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
PRNewswire (Tue, 14-Jul 7:00 AM ET)
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
PRNewswire (Mon, 13-Jul 7:30 AM ET)
Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
PRNewswire (Tue, 2-Jun 7:30 AM ET)
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026
PRNewswire (Fri, 22-May 4:30 PM ET)
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Zimmer Biomet Holdings trades on the NYSE stock market under the symbol ZBH.
As of August 5, 2026, ZBH stock price climbed to $98.16 with 4,980,018 million shares trading.
ZBH has a beta of 0.73, meaning it tends to be less sensitive to market movements. ZBH has a correlation of 0.08 to the broad based SPY ETF.
ZBH has a market cap of $19.21 billion. This is considered a Large Cap stock.
Last quarter Zimmer Biomet Holdings reported $2 billion in Revenue and $2.09 earnings per share. This beat revenue expectation by $21 million and exceeded earnings estimates by $.23.
In the last 3 years, ZBH traded as high as $133.90 and as low as $79.12.
The top ETF exchange traded funds that ZBH belongs to (by Net Assets): VTI, VOO, MOAT, IVV, SPY.
ZBH has underperformed the market in the last year with a return of +7.3%, while SPY returned +23.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ZBH shares. However, ZBH has outperformed the market in the last 3 month and 2 week periods, returning +19.0% and +10.4%, while SPY returned +7.5% and +2.9%, respectively. This indicates ZBH has been having a stronger performance recently.
ZBH support price is $93.69 and resistance is $97.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ZBH shares will trade within this expected range on the day.